Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 20 studies | 32% ± 16% | |
non-classical monocyte | 8 studies | 30% ± 13% | |
plasmacytoid dendritic cell | 8 studies | 25% ± 10% | |
platelet | 7 studies | 24% ± 8% | |
plasma cell | 5 studies | 22% ± 5% | |
hematopoietic precursor cell | 4 studies | 25% ± 7% | |
classical monocyte | 3 studies | 25% ± 7% | |
megakaryocyte | 3 studies | 55% ± 4% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 41% ± 15% | |
monocyte | 3 studies | 24% ± 4% | |
hematopoietic stem cell | 3 studies | 24% ± 7% |
Insufficient scRNA-seq data for expression of P2RX1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 5346.57 | 328 / 328 | 81% | 4.79 | 145 / 178 |
prostate | 93% | 2609.17 | 229 / 245 | 88% | 5.60 | 440 / 502 |
lung | 97% | 1480.08 | 563 / 578 | 79% | 2.97 | 913 / 1155 |
bladder | 95% | 14849.48 | 20 / 21 | 52% | 3.43 | 263 / 504 |
intestine | 88% | 2107.07 | 852 / 966 | 58% | 1.72 | 305 / 527 |
esophagus | 76% | 1283.49 | 1104 / 1445 | 50% | 1.96 | 92 / 183 |
uterus | 78% | 1357.59 | 132 / 170 | 45% | 2.04 | 206 / 459 |
stomach | 44% | 395.96 | 159 / 359 | 67% | 2.49 | 191 / 286 |
spleen | 100% | 3815.59 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 5226.25 | 851 / 929 | 0% | 0 | 0 / 0 |
skin | 36% | 487.11 | 659 / 1809 | 39% | 1.22 | 183 / 472 |
kidney | 13% | 131.87 | 12 / 89 | 59% | 1.55 | 536 / 901 |
blood vessel | 70% | 12914.76 | 933 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 62% | 4.12 | 18 / 29 |
tonsil | 0% | 0 | 0 / 0 | 60% | 1.53 | 27 / 45 |
breast | 15% | 210.85 | 67 / 459 | 41% | 1.09 | 455 / 1118 |
ovary | 28% | 340.84 | 50 / 180 | 21% | 0.53 | 92 / 430 |
adipose | 44% | 1176.93 | 524 / 1204 | 0% | 0 | 0 / 0 |
thymus | 6% | 54.05 | 37 / 653 | 31% | 1.26 | 188 / 605 |
adrenal gland | 5% | 37.58 | 12 / 258 | 23% | 0.91 | 54 / 230 |
brain | 1% | 3.66 | 17 / 2642 | 18% | 0.43 | 124 / 705 |
liver | 1% | 6.66 | 2 / 226 | 15% | 0.34 | 62 / 406 |
heart | 14% | 106.26 | 121 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.13 | 3 / 80 |
muscle | 1% | 19.05 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007320 | Biological process | insemination |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0033198 | Biological process | response to ATP |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0007165 | Biological process | signal transduction |
GO_0008217 | Biological process | regulation of blood pressure |
GO_0006811 | Biological process | monoatomic ion transport |
GO_0035590 | Biological process | purinergic nucleotide receptor signaling pathway |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_0030168 | Biological process | platelet activation |
GO_0019228 | Biological process | neuronal action potential |
GO_0099509 | Biological process | regulation of presynaptic cytosolic calcium ion concentration |
GO_0006915 | Biological process | apoptotic process |
GO_0003056 | Biological process | regulation of vascular associated smooth muscle contraction |
GO_1905665 | Biological process | positive regulation of calcium ion import across plasma membrane |
GO_0002554 | Biological process | serotonin secretion by platelet |
GO_2000300 | Biological process | regulation of synaptic vesicle exocytosis |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0035249 | Biological process | synaptic transmission, glutamatergic |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0048787 | Cellular component | presynaptic active zone membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0001614 | Molecular function | purinergic nucleotide receptor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005261 | Molecular function | monoatomic cation channel activity |
GO_0099604 | Molecular function | ligand-gated calcium channel activity |
GO_0043924 | Molecular function | suramin binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004931 | Molecular function | extracellularly ATP-gated monoatomic cation channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | P2RX1 |
Protein name | Purinergic receptor P2X1 ATP receptor (Purinergic receptor) Purinergic receptor P2X 1 P2X purinoceptor 1 (P2X1) (ATP receptor) (Purinergic receptor) |
Synonyms | P2X1 |
Description | FUNCTION: Ligand-gated ion channel with relatively high calcium permeability. Binding to ATP mediates synaptic transmission between neurons and from neurons to smooth muscle. Seems to be linked to apoptosis, by increasing the intracellular concentration of calcium in the presence of ATP, leading to programmed cell death (By similarity). . |
Accessions | ENST00000225538.4 P51575 K4JYE8 ENST00000571637.1 I3L3H3 Q6PIW1 |